Literature DB >> 18410253

Plasmapheresis in asparaginase-induced hypertriglyceridemia.

Elizabeth M Kfoury-Baz1, Rabih A Nassar, Rita F Tanios, Zaher K Otrock, Amira M Youssef, Costantine Albany, Ali Bazarbachi, Ziad M Salem.   

Abstract

BACKGROUND: Asparaginase is an essential component of the chemotherapy regimens during the induction and intensification phases for acute lymphoblastic leukemia and lymphoblastic lymphoma. The administration of asparaginase can cause elevation of the triglyceride levels. CASE REPORT: This study reports the case of an adult patient presenting with acute pancreatitis secondary to severe hypertriglyceridemia after asparaginase treatment during the consolidation phase of lymphoblastic lymphoma. This condition was successfully treated with plasmapheresis.
CONCLUSIONS: Our case demonstrates that plasmapheresis in severe cases of hypertriglyceridemia offers a safe and efficient treatment option for symptomatic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410253     DOI: 10.1111/j.1537-2995.2008.01663.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Pseudohyponatraemia due to L-asparaginase-associated dyslipidaemia in T-cell lymphoblastic lymphoma.

Authors:  Jaimal Kothari; Alison Thomas; Anthony Goldstone
Journal:  BMJ Case Rep       Date:  2014-03-31

2.  Severe L-asparaginase-induced Hypertriglyceridaemia Treated with Plasmapheresis.

Authors:  José Silvano; Nidia Marques; Isabel Tavares; Ines Ferreira
Journal:  Eur J Case Rep Intern Med       Date:  2021-02-18

Review 3.  Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Authors:  Kjeld Schmiegelow; Klaus Müller; Signe Sloth Mogensen; Pernille Rudebeck Mogensen; Benjamin Ole Wolthers; Ulrik Kristoffer Stoltze; Ruta Tuckuviene; Thomas Frandsen
Journal:  F1000Res       Date:  2017-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.